Paragon 28 Future Growth
Future criteria checks 1/6
Paragon 28 is forecast to grow earnings and revenue by 27% and 14% per annum respectively while EPS is expected to grow by 29.8% per annum.
Key information
27.0%
Earnings growth rate
29.8%
EPS growth rate
Medical Equipment earnings growth | 17.1% |
Revenue growth rate | 14.0% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 15 Nov 2024 |
Recent future growth updates
Analysts Have Made A Financial Statement On Paragon 28, Inc.'s (NYSE:FNA) Third-Quarter Report
Nov 15Recent updates
Analysts Have Made A Financial Statement On Paragon 28, Inc.'s (NYSE:FNA) Third-Quarter Report
Nov 15It's Down 28% But Paragon 28, Inc. (NYSE:FNA) Could Be Riskier Than It Looks
Oct 03We Think Paragon 28 (NYSE:FNA) Has A Fair Chunk Of Debt
Sep 18Investors Give Paragon 28, Inc. (NYSE:FNA) Shares A 27% Hiding
Jun 24Is Paragon 28 (NYSE:FNA) Using Too Much Debt?
Jun 07Many Still Looking Away From Paragon 28, Inc. (NYSE:FNA)
Apr 17Paragon 28, Inc. (NYSE:FNA) Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Mar 03After Leaping 29% Paragon 28, Inc. (NYSE:FNA) Shares Are Not Flying Under The Radar
Nov 28Paragon 28 announces public offering of 6.5M shares
Jan 25Paragon 28 guides Q4 and FY22 revenue outlook above consensus
Jan 10Paragon 28 GAAP EPS of -$0.13 misses by $0.01, revenue of $46M beats by $3.52M
Nov 10US$25.00: That's What Analysts Think Paragon 28, Inc. (NYSE:FNA) Is Worth After Its Latest Results
May 12Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 334 | -30 | N/A | N/A | 6 |
12/31/2025 | 292 | -40 | N/A | N/A | 7 |
12/31/2024 | 254 | -54 | N/A | N/A | 7 |
9/30/2024 | 245 | -56 | -59 | -40 | N/A |
6/30/2024 | 235 | -55 | -74 | -52 | N/A |
3/31/2024 | 225 | -54 | -87 | -61 | N/A |
12/31/2023 | 216 | -48 | -92 | -64 | N/A |
9/30/2023 | 207 | -74 | -91 | -61 | N/A |
6/30/2023 | 201 | -73 | -88 | -59 | N/A |
3/31/2023 | 192 | -69 | -81 | -54 | N/A |
12/31/2022 | 181 | -67 | -92 | -49 | N/A |
9/30/2022 | 173 | -33 | -84 | -38 | N/A |
6/30/2022 | 162 | -29 | -75 | -31 | N/A |
3/31/2022 | 156 | -22 | -58 | -17 | N/A |
12/31/2021 | 147 | -14 | -25 | -3 | N/A |
9/30/2021 | 140 | -5 | -10 | 4 | N/A |
6/30/2021 | 134 | 4 | -9 | 4 | N/A |
3/31/2021 | 121 | 4 | -7 | 4 | N/A |
12/31/2020 | 111 | 3 | -10 | 1 | N/A |
12/31/2019 | 106 | 3 | -6 | 12 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: FNA is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: FNA is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: FNA is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: FNA's revenue (14% per year) is forecast to grow faster than the US market (8.9% per year).
High Growth Revenue: FNA's revenue (14% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if FNA's Return on Equity is forecast to be high in 3 years time